Kenneth E Thompson

US Patent:

58259767, Oct 20, 1998

Filed:

Apr 18, 1996

Appl. No.:

8/634538

Inventors:

Sean Matthew Dorward - Somerville NJ
Nuggehally Sampath Jayant - Gillette NJ
James David Johnston - Warren NJ
Schuyler Reynier Quackenbush - Westfield NJ
Kenneth Lane Thompson - Watchung NJ

Assignee:

Lucent Technologies Inc. - Murray Hill NJ

International Classification:

G10L 300
G10L 900

US Classification:

395 238

Abstract:

An independent transport layer is used as an error correction mechanism in a method employing perceptual audio coding. The transport layer is characterized by the addition of information, via a transport header, to each of a succession of blocks of encoded program material which is independent of the information within its respective block of encoded program material. The transport header comprises information on the structure of the block. Thus, the transport header is easily separated from the digital representation of the program material and is independent of the content of the digital representation thereby providing for changing of the content of the digital representation without changing the transport layer.

US Patent:

20220387433, Dec 8, 2022

Filed:

Nov 10, 2020

Appl. No.:

17/775794

Inventors:

- Shirley NY, US
Kenneth C. Thompson - Hillsborough NJ, US
Sanjay Kumar Singh - South Setauket NY, US

Assignee:

American Regent, Inc. - Shirley NY

International Classification:

A61K 31/519
A61K 9/00
A61K 31/517
A61K 31/506
A61K 31/13
A61K 31/53
A61K 38/00

Abstract:

Methods of preventing or treating elevated pulmonary vascular pressure or exercise-induced pulmonary hemorrhage in mammals are provided, the methods comprise administering compositions comprising type V phosphodiesterase inhibitors and an organic base (e.g., meglumine) to the mammal. Compositions, kits and methods of making type V phosphodiesterase inhibitor are also provided. In one embodiment, the composition comprises E-4021, which is sodium 1-[6-chloro-4-(3,4-methylenedioxybenzyl)-aminoquinazolin-2-yl]piperidine-4-carboxylate sesquihydrate and meglumine.